Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia
On Aug. 18, 2020, Vanda Pharma reported that interim analysis showed tradipitant may accelerate clinical improvement in SARS-CoV-2…